XORTX Therapeutics Inc (NASDAQ:XRTX) does about 2.78M shares in volume on a normal day but saw 1578962 shares change hands in the recent trading day. The company now has a market cap of 5.42M USD. Its current market price is $1.87, marking an increase of 23.03% compared to the previous close of $1.52. The 52 week high reached by this stock is $7.52 whilst the lowest price level in 52 weeks is $1.09.
XORTX Therapeutics Inc (XRTX) has a 20-day trading average at $1.6306 and the current price is -75.15% off the 52-week high compared with 71.56% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.6618 and its 200-day simple moving average is $2.4414. If we look at the stock’s price movements over the week, volatility stands at 21.32%, which decreases to 13.04% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 57.27 to suggest the stock is neutral.
The consensus objective for the share price is $14.00, suggesting that the stock has a potential upside of 86.64% over the period.
The current price level is 14.68%, 12.53%, and -23.40% away from its SMA20, SMA50, and SMA200 respectively, with the XRTX price moving below the 50-day SMA on current market day. XORTX Therapeutics Inc (XRTX) stock is up 3.89% over the week and 0.54% over the past month. Its price is -19.05% year-to-date and -46.72% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/30/2023, with the company’s earnings per share (EPS) of -1.34 above consensus estimates by 0.46. The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
To reach the target analysts have set, the stock logically needs to grow 86.64 percent from here.
The company has a return on investment of -54.83% and return on equity of -29.36%. Price to book ratio is 2.01.
